Discovery of small molecule therapeutics for the Middle Eastern respiratory syndrome-coronavirus (MERS-CoV)
Middle-Eastern Respiratory Syndrome (MERS) is a coronavirus infection which affects the lower respiratory tract of infected individuals. Its high mortality rate of 34.5% led MERS to be listed as a high priority disease for research by the World Health Organisation (WHO). MERS can be both symptomatic...
Saved in:
Main Author: | Gan, Jonathan Hanjie |
---|---|
Other Authors: | Yoon Ho Sup |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/137291 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
The middle east respiratory syndrome coronavirus (MERS-CoV) and Singapore
by: Tambyah, P.A., et al.
Published: (2016) -
VIRUS-HOST INTERACTIONS OF THE MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS (MERS-COV) NUCLEOCAPSID PROTEIN
by: JAMES ODAME ABOAGYE
Published: (2020) -
Imported case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection from Oman to Thailand, June 2015
by: T. Plipat, et al.
Published: (2018) -
MODEL PENYEBARAN MIDDLE EAST RESPIRATORY SYNDROME (MERS) DENGAN PENGARUH PENGOBATAN
by: Lazarus Kalvein Beay
Published: (2017) -
Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug
by: Gan, Hanjie Jonathan, et al.
Published: (2022)